Bioimpedance Analyzer Market Analysis

Bioimpedance Analyzer Market Analysis

Based on product, the global bioimpedance analyzer industry is classified into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The multi-frequency bioimpedance analyzers segment dominated the global market by securing a significant share and is expected to grow at a CAGR of 10.9% between 2024 – 2032.
 

• The dominance is propelled by increased accuracy and enhanced precision output over single- and dual-frequency analyzers, broad applicability across wide range of population, and owing to their capability to offer better measurement reproducibility.
   

Based on modality, the market is classified into wired analyzers and wireless analyzers. The wired analyzers segment is expected to witness a growth rate of 10.7% during the forecast period. This rapid growth rate can be attributed to their ease of use, remote monitoring capabilities, and their growing applications in sports and fitness related activities.
 

Based on the usage type, the bioimpedance analyzer market is segmented into professional-grade analyzers, and consumer-grade analyzers. The professional-grade analyzers segment dominated the market accounting for a share of 64.2% in 2023.
 

• High use of professional-grade analyzers across multiple applications is a crucial driving factor contributing to their revenue growth in the market. The multiple applications include body composition analysis, nutritional assessment, fluid status monitoring, and disease diagnosis.
   
• Professional-grade analyzers are also finding significant adoption in research and development activities across fields such as nutrition, sports science, exercise physiology, and biomedical engineering. Increasing growth in investments for research and development globally is surging the utilization of professional-grade analyzers.
   

Based on the application, the bioimpedance analyzer industry is segmented into segmental body measurement and whole-body measurement. Segmental body measurement segment dominated the market with a revenue of about USD 397.8 million in 2023.
 

• Increasing demand for precise and accurate measurement of body compositions in a specific body part is driving the demand for segmental body measurements. Certain health conditions and risk factors (such as abdominal fat accumulation, lower body fat distribution) are associated with specific body segments, and segmental body measurement offers clinically relevant information for risk assessment, treatment planning, and disease management.
   
• Majority of fitness clubs and wellbeing centers relies on segmental body measurement to evaluate muscle symmetry, strength imbalances, and injury risk factors, as a result with an increase in number of fitness clubs and wellbeing centers, the demand for segmental body measurement has increased globally.
   

Based on the end user, the market is classified into fitness clubs and well-being center, hospitals and clinics, home users, and other end users. The fitness clubs and well-being center segment is expected to reach USD 556.5 million by the end of 2032.
 

• Fitness clubs and well-being center dominate the bioimpedance analyzer market due to their multiple applications across these centers in monitoring body compositions, tracking fitness goals, devising personalized fitness and nutrition recommendations, and in facilitating the targeted interventions to improve health and fitness.
  
   

North America region is projected to maintain its dominance in the global market and is anticipated to reach USD 474.5 million by 2032.
 

• The dominance of North America can be attributed to several factors including high awareness on health and wellness activities, significant growth in wellness and fitness industry, and presence of policies promoting preventive healthcare and wellness initiatives along with insurance coverage for specific health evaluations and treatments, that promotes the use of bioimpedance analyzers in both clinical and non-clinical environments.
   

U.S. bioimpedance analyzer industry was valued at USD 179.7 million in 2023.
 

• Growing awareness towards health and fitness activities and growing demand for body composition monitoring in sports and fitness clubs is driving the revenue growth in the market.
   
• Furthermore, availability of bioimpedance analyzers with advanced features and technologies, and presence of advanced healthcare infrastructure is also supporting the revenue growth in the bioimpedance analyzers market.
   

UK dominated the market in Europe owing to increase in lifestyle disorders, and growing number of fitness clubs; sports rehabilitation centers; and weight loss centers in the country. According to the House of Commons Library published in January 2023, 25.9% of adults in England were obese. Increasing obesity rates are driving the demand for body fat composition monitoring, thereby driving the demand for bioimpedance analyzers.
 

China bioimpedance analyzer market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Increasing partnerships and collaboration among local manufacturers and international distributors and suppliers to further explore opportunities in countries offering lucrative markets is driving the revenue growth for local manufacturers of bioimpedance analyzers in China.
   
• Moreover, growing awareness for the diagnosis and treatment of lifestyle related disorders, and growing access to advanced healthcare technologies and infrastructure is further supporting the revenue growth of the market.